Neurogenic pulmonary edema following acute stroke: The progress and perspective - 27/10/20
pages | 8 |
Iconographies | 2 |
Vidéos | 0 |
Autres | 0 |
Abstract |
Neurogenic pulmonary edema (NPE) following acute stroke is an acute respiratory distress syndrome (ARDS) with clinical characteristics that include acute onset, apparent pulmonary interstitial fluid infiltration and rapid resolution. The pathological process of NPE centers on sympathetic stimulation and fulminant release of catecholamines, which cause contraction of resistance vessels. Elevated systemic resistance forces fluid into pulmonary circulation, while pulmonary circulation overload induces pulmonary capillary pressure that elevates, and in turn damages the alveolar capillary barrier. Damage to the alveolar capillary barrier leads to pulmonary ventilation disorder, blood perfusion disorder and oxygenation disorder. Eventually, NPE will cause post-stroke patients’ prognosis to further deteriorate. At present, we lack specific biological diagnostic indicators and a meticulously unified diagnostic criterion, and this results in a situation in which many patients are not recognized quickly and/or diagnosed accurately. There are no drugs that are effective against NPE. Therefore, understanding how to diagnose NPE early by identifying the risk factors and how to apply appropriate treatment to avoid a deteriorating prognosis are important scientific goals. We will elaborate the progress of NPE after acute stroke in terms of its pathophysiological mechanisms, etiology, epidemiology, clinical diagnosis and early prediction, comprehensive treatment strategies, and novel drug development. We also propose our own thinking and prospects regarding NPE.
Le texte complet de cet article est disponible en PDF.Abbreviations : NPE, ARDS, CNS, ICH, SAH, TBI, SUDEP, ICP, RVLM, NMDA, GABA, BBB, ROS, ROC, AUC, β2-ARs, Gs, Gi, α-ARs, IL-1, IL-6, IL-8, Ic, TTC, TNF, WFNS, BNP, HRV, TP, LF%, ECG, NSSTTCs, CPK, CPK-MB, TTE, TPTD, PVPI, PICCO, EVLWI, GEDVI, ITBVI, LTVV, PEEP, CPP, ECMO, KATP, UTI, ET-1, HES, OPN, VEGF, VPA, UFH, P2×7R, CB2R, ICAM-1, VCAM-1, MIP, CINC-1, MPO, TJ, JAM, MMP9, MAP, EAA, IAA, CMR, CBF, ZO-1, BBG, Ac-YVAD-CMK, ACEI, ACE, RAS, AngII
Keywords : Neurogenic pulmonary edema, Stroke, Progress
Plan
Vol 130
Article 110478- octobre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?